We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current PALI market cap is 3.11M. The company's latest EPS is USD -3.2839 and P/E is -0.46.
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -3.15M | -3.67M | -4.21M | -3.59M | -3.38M |
| Net Income | -2.97M | -3.53M | -4.08M | -3.49M | -3.34M |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 14k | 0 | 0 | 250k | 0 |
| Operating Income | -10.69M | -41.85M | -15.72M | -13.07M | -14.86M |
| Net Income | -16.28M | -26.62M | -14.26M | -12.3M | -14.44M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 14.05M | 12.65M | 12.87M | 9.34M | 10.88M |
| Total Liabilities | 2.74M | 2.59M | 2.92M | 2.73M | 3.39M |
| Total Equity | 11.31M | 10.06M | 9.95M | 6.61M | 7.49M |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 13.05M | 12.51M | 15.76M | 14.05M | 10.88M |
| Total Liabilities | 3.28M | 5.15M | 3.28M | 2.74M | 3.39M |
| Total Equity | 9.77M | 7.37M | 12.48M | 11.31M | 7.49M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -11.13M | -3.18M | -6.68M | -9.81M | -12.19M |
| Investing | -4k | N/A | N/A | N/A | N/A |
| Financing | 11.19M | 2.02M | 5.6M | 5.42M | 9.58M |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -9.03M | -14.77M | -13.36M | -11.13M | -12.19M |
| Investing | N/A | -54k | -10k | -4k | N/A |
| Financing | 14.47M | 24.61M | 15.26M | 11.19M | 9.58M |
| Market Cap | 3.11M |
| Price to Earnings Ratio | -0.46 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0.68 |
| Price to Book Ratio | 0.89 |
| Dividend Yield | - |
| Shares Outstanding | 4.4M |
| Average Volume (1 week) | 35.55k |
| Average Volume (1 Month) | 57.43k |
| 52 Week Change | -84.80% |
| 52 Week High | 9.09 |
| 52 Week Low | 0.60 |
| Spread (Intraday) | 0.04 (5.82%) |
| Company Name | Palisade Bio Inc |
| Address |
2140 s dupont hwy camden, delaware 19934 |
| Website | https://www.palisadebio.com. |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
